Cargando…
Co-Occurrence of Myeloid and Lymphoid Neoplasms: Clinical Characterization and Impact on Outcome. A Single-Center Cohort Study
The co-occurrence of myeloid neoplasms and lymphoproliferative diseases (LPDs) has been epidemiologically described, particularly in myeloproliferative neoplasms (MPNs). However, the clinical features of these patients are poorly known. In this study, we evaluated a single-center cohort of 44 patien...
Autores principales: | Bucelli, Cristina, Fattizzo, Bruno, Cattaneo, Daniele, Giannotta, Juri Alessandro, Barbullushi, Kordelia, Pasquale, Raffaella, Barozzi, Enrico, Barbanti, Maria Chiara, Pettine, Loredana, Rossi, Francesca Gaia, Reda, Gianluigi, Cassin, Ramona, Barcellini, Wilma, Baldini, Luca, Iurlo, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558405/ https://www.ncbi.nlm.nih.gov/pubmed/34733777 http://dx.doi.org/10.3389/fonc.2021.701604 |
Ejemplares similares
-
Reply to “COVID-19 in persons with haematological cancers”: a focus on myeloid neoplasms and risk factors for mortality
por: Fattizzo, Bruno, et al.
Publicado: (2020) -
Autoimmune Hemolytic Anemia as a Complication of Congenital Anemias. A Case Series and Review of the Literature
por: Motta, Irene, et al.
Publicado: (2021) -
Autoimmune Complications in Hematologic Neoplasms
por: Barcellini, Wilma, et al.
Publicado: (2021) -
Off-Label Use of Thrombopoietin Receptor Agonists: Case Series and Review of the Literature
por: Capecchi, Marco, et al.
Publicado: (2021) -
Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic Patients
por: Fattizzo, Bruno, et al.
Publicado: (2022)